From Fragmented Campaigns to a Patient Acquisition System
How rebuilding the marketing infrastructure at a leading proton therapy center produced 62% growth in patient starts.
62%
Increase in Patient Starts
~18%
Reduction in Cost Per Start
34%
Increase in Organic Traffic
The Situation
Proton therapy is one of the most complex patient acquisition environments in healthcare. Treatments are highly specialized. Decision cycles are long. Physician referrals, insurance approvals, and patient education all factor into whether someone makes it from initial inquiry to first treatment.
When Marant Digital was engaged, the center had operated without dedicated marketing leadership for over a year. Campaigns were running. Spend was flowing. But nobody owned the strategy connecting that activity to clinical growth.
Three structural problems had developed:
-
No unified channel strategy. Paid search, paid social, SEO, and content initiatives were each operating independently, with no shared framework for investment or prioritization.
-
No funnel visibility. Leadership couldn't track how inquiries moved through the pipeline, where they stalled, or what was actually driving patient starts.
-
No accountability architecture. Multiple agencies were executing campaigns, but strategic oversight was absent. There was no clear owner for performance.
What We Built
The engagement was structured as a growth infrastructure rebuild, not a campaign refresh. The goal was to create the system connecting demand generation with clinical conversion, then optimize the parts.
Patient Acquisition Funnel Architecture
Inquiry
Restructured paid search around high-intent oncology queries. Messaging aligned to where patients are in their decision process, not just treatment awareness.
↓
Lead
Intake workflows and conversion paths rebuilt to reduce drop-off between digital inquiry and first contact.
↓
Consult
Content and SEO expanded to build search authority across treatment-specific pathways, including emerging AI-driven search surfaces.
↓
Simulation
Campaign performance and clinical pipeline data connected, enabling visibility into conversion at each stage.
↓
Patient Start
Strategic oversight centralized across all agencies. Investment decisions tied to pipeline outcomes, not activity metrics.
Growth didn't come from more marketing activity. It came from rebuilding the system itself.
Results
Within two years, the center produced significant improvements in both volume and efficiency.
Patient starts increased 62%. That growth was achieved without proportional increases in marketing spend, which means the gains came from better conversion across the pipeline, not from buying more traffic.
Cost per patient start improved approximately 18% year-over-year. The efficiency gains were most pronounced in the deeper clinical stages, consults and simulations, where stronger marketing-to-operations alignment had the most direct impact.
Organic traffic grew 34%, reflecting improved search authority across both traditional and AI-driven platforms.
What This Means for Other Programs
Most healthcare organizations try to solve patient growth by adding more marketing tactics. More channels, more spend, more campaigns. That instinct is understandable, but it often misses the actual problem.
When the underlying acquisition architecture is broken, more activity just amplifies the inefficiency. You end up with higher spend, crowded reporting, and no clearer picture of what's working.
What produced growth here was structural: aligning market demand, patient education, clinical intake, and conversion into a single, visible system. Once that system was in place, every optimization had somewhere to land.
The model applies to any proton therapy program, or any complex specialty, facing the same pattern: marketing activity without infrastructure, spend without visibility, agencies without strategic direction.